[Bora] Acquires CDMO Operating Assets Through Newly Established Subsidiary Bora Biologics USA LLC
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Bora is acquiring CDMO operating assets in Maryland, USA, for USD 122.5 million through its newly established subsidiary, Bora Biologics USA LLC. This strategic move aims to accelerate the expansion of its commercial large-scale CDMO business in North America. MacroGenics, Inc. is the seller.